Since MSCs possess the hereditary expression of PD‐L1 and HGF, genetically engineering these cells to overexpress the two molecules might be a good strategy for rescuing the neuroglial tissue injured by stroke, to enhance treatment efficacy. The gene discussed is HGF; the disease is Stroke.